Scholar Rock Files 2024 10-K
Ticker: SRRK · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1727196
Sentiment: neutral
Topics: 10-K, financials, biotech
TL;DR
SRRK 2024 10-K filed. Financials for FY24 out.
AI Summary
Scholar Rock Holding Corp. filed its 2024 10-K on February 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, located at 301 Binney Street, Cambridge, MA, operates in the biological products sector. Key financial data points such as retained earnings, additional paid-in capital, and accumulated other comprehensive income are reported for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides investors with a comprehensive overview of Scholar Rock's financial health and operational performance for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a biotechnology company, Scholar Rock is subject to inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 75,979,495 — Total Assets (Reported for fiscal year 2024)
- 93,823,678 — Total Liabilities (Reported for fiscal year 2024)
Key Players & Entities
- Scholar Rock Holding Corp. (company) — Filer of the 10-K
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA 02142 (company) — Business and mailing address
- 20241231 (date) — Fiscal year end
- 20250227 (date) — Filing date
- 001-38501 (dollar_amount) — SEC File Number
FAQ
What was Scholar Rock's net income or loss for the fiscal year ended December 31, 2024?
The provided excerpt does not contain specific net income or loss figures for the fiscal year ended December 31, 2024. It focuses on balance sheet items like retained earnings and capital.
What are the key segments or therapeutic areas Scholar Rock is focused on?
The filing indicates Scholar Rock is in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' SIC code, but specific therapeutic areas are not detailed in this excerpt.
Did Scholar Rock engage in any significant financing activities during the period covered by the 10-K?
The filing mentions 'us-gaap:OverAllotmentOptionMember' and 'srrk:UnderwritingAgreementMember' related to the period of October 1, 2024, to October 31, 2024, suggesting potential equity offerings.
What is the company's cash position as of December 31, 2024?
Specific cash and cash equivalents are not detailed in the provided excerpt of the 10-K.
What were the total revenues for Scholar Rock in the fiscal year 2024?
Revenue figures for the fiscal year 2024 are not present in the provided text.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Scholar Rock Holding Corp (SRRK).